Chevron Corporation (NYSE: CVX), a stalwart in the integrated oil and gas industry, stands as one of the largest players in the energy sector, boasting a market capitalization of $368.32..
Candel Therapeutics, Inc. (NASDAQ: CADL), a burgeoning player in the biotechnology sector, is drawing attention from investors with its innovative approach to cancer treatment and a remarkable potential upside of..
ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a pivotal player in the technology sector, particularly within the application software industry. Known for its advanced go-to-market intelligence platform, ZoomInfo caters to..
Erasca, Inc. (NASDAQ: ERAS) stands at the forefront of precision oncology, focusing on the discovery and development of therapies targeting RAS/MAPK pathway-driven cancers. With a market capitalization of $4.17 billion,..
Asure Software Inc (NASDAQ: ASUR), a key player in the cloud-based Human Capital Management (HCM) software sector, has captured investor attention with its compelling growth prospects and a potential 78.20%..
NetClass Technology Inc (NTCL), a Singapore-based player in the Technology sector, specifically within the Software – Application industry, has captured attention due to its intriguing 52-week price range of $0.25..
Materialise NV (NASDAQ: MTLS) is carving its niche in the dynamic world of 3D printing and additive manufacturing. Headquartered in Leuven, Belgium, this technology company is a prominent player within..
Sanara MedTech Inc. (NASDAQ: SMTI) is positioning itself as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of approximately..
CytomX Therapeutics, Inc. (NASDAQ: CTMX) is emerging as a compelling player in the biotechnology sector with a strong focus on oncology. Operating out of South San Francisco, California, the company..
Neuronetics, Inc. (NASDAQ: STIM), a healthcare company recognized for its innovative medical devices, is garnering significant attention from investors, thanks to its remarkable upside potential. With a market capitalization of..
Neurogene Inc. (NGNE), a pioneering player in the biotechnology sector, is attracting attention from investors due to its promising pipeline of genetic medicines targeting rare neurological disorders. With a current..
Grab Holdings Limited (NASDAQ: GRAB), a leading player in the technology sector, is capturing attention with its innovative superapp platform across Southeast Asia. With a market capitalization of $17.21 billion,..
Porch Group, Inc. (NASDAQ: PRCH) has caught the attention of investors with its recent performance and significant potential upside. Operating in the Financial Services sector, specifically within the Insurance –..
Compass Therapeutics, Inc. (NASDAQ: CMPX) is capturing the attention of investors with a remarkable potential upside of 130.41%, according to the latest analyst ratings. As a clinical-stage oncology-focused biopharmaceutical company..
Aura Biosciences, Inc. (NASDAQ: AURA) is emerging as a compelling player in the biotechnology sector, capturing investor interest with its innovative approach to cancer treatment and a potential upside of..
Cytek Biosciences, Inc. (CTKB), a promising player in the healthcare sector, is attracting attention from investors with its innovative cell analysis tools and potential upside of 37.30%. Despite its current..
National Research Corporation (NRC), trading on the U.S. exchange in the healthcare sector, specializes in health information services, providing an essential suite of analytics and insights for healthcare organizations. With..
For investors navigating the healthcare sector, Health Catalyst, Inc. (NASDAQ: HCAT) offers an intriguing opportunity with its robust data and analytics technology services for healthcare organizations. Based in South Jordan,..
Nyxoah SA (NYSE: NYXH), a Belgium-based healthcare company specializing in medical instruments and supplies, is capturing investor attention with a notable potential upside of 149.14%. As the developer of the..
Investors with a penchant for high-risk, high-reward opportunities in the biotechnology sector may find aTyr Pharma, Inc. (NASDAQ: ATYR) an intriguing prospect. With a market capitalization of $99.95 million, this..
